Multiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1 in a patient with bilateral breast and endometrial adenocarcinoma

BACKGROUND: Germline genetic testing for familial cancer syndromes is usually performed serially for the most likely genetic causes. In recent years the way genetic testing carried out has changed, as next generation sequencing now allows the simultaneous testing of multiple susceptibility genes at...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Heitzer, Ellen, Lax, Sigurd, Lafer, Ingrid, Müller, Stephanie M, Pristauz, Gunda, Ulz, Peter, Jahn, Stephan, Högenauer, Christoph, Petru, Edgar, Speicher, Michael R, Geigl, Jochen B
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3913615/
https://ncbi.nlm.nih.gov/pubmed/24373500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2350-14-129
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados